Matches in SemOpenAlex for { <https://semopenalex.org/work/W2751881420> ?p ?o ?g. }
- W2751881420 endingPage "894" @default.
- W2751881420 startingPage "881" @default.
- W2751881420 abstract "The therapeutic efficacy of conventional chemotherapy against several solid tumors is generally limited and this is often due to the development of resistance or poor delivery of the drugs to the tumor. Mechanisms of resistance may vary between cancer types. However, with current development of genetic analyses, imaging, and novel delivery systems, we may be able to characterize and bypass resistance, e.g., by inhibition of the right target at the tumor site. Therefore, combined drug treatments, where one drug will revert or obstruct the development of resistance and the other will concurrently kill the cancer cell, are rational solutions. However, drug exposure of one drug will defer greatly from the other due to their physicochemical properties. In this sense, multi-compound nanoparticles are an excellent modality to equalize drug exposure, i.e., one common physicochemical profile. In this review, we will discuss novel approaches that employ nanoparticle technology that addresses specific mechanisms of resistance in cancer.The PubMed literature was consulted and reviewed.Nanoparticle technology is emerging as a dexterous solution that may address several forms of resistance in cancer. For instance, we discuss advances that address mechanisms of resistance with multi-compound nanoparticles which co-deliver chemotherapeutics with an anti-resistance agent. Promising anti-resistance agents are (1) targeted in vivo gene silencing methods aimed to disrupt key resistance gene expression or (2) protein kinase inhibitors to disrupt key resistance pathways or (3) efflux pumps inhibitors to limit drug cellular efflux." @default.
- W2751881420 created "2017-09-15" @default.
- W2751881420 creator A5022741034 @default.
- W2751881420 creator A5035296183 @default.
- W2751881420 creator A5035490415 @default.
- W2751881420 creator A5068102754 @default.
- W2751881420 date "2017-09-08" @default.
- W2751881420 modified "2023-10-14" @default.
- W2751881420 title "The potential of multi-compound nanoparticles to bypass drug resistance in cancer" @default.
- W2751881420 cites W1492360552 @default.
- W2751881420 cites W1517036148 @default.
- W2751881420 cites W1517930470 @default.
- W2751881420 cites W1570824425 @default.
- W2751881420 cites W178248364 @default.
- W2751881420 cites W1790507666 @default.
- W2751881420 cites W1865572427 @default.
- W2751881420 cites W1873396860 @default.
- W2751881420 cites W1887030992 @default.
- W2751881420 cites W1953808829 @default.
- W2751881420 cites W1959505660 @default.
- W2751881420 cites W1963526834 @default.
- W2751881420 cites W1965636780 @default.
- W2751881420 cites W1969313893 @default.
- W2751881420 cites W1972461780 @default.
- W2751881420 cites W1973345865 @default.
- W2751881420 cites W1974598896 @default.
- W2751881420 cites W1975001648 @default.
- W2751881420 cites W1976041621 @default.
- W2751881420 cites W1976557226 @default.
- W2751881420 cites W1978640331 @default.
- W2751881420 cites W1978940302 @default.
- W2751881420 cites W1981072770 @default.
- W2751881420 cites W1982637919 @default.
- W2751881420 cites W1983718760 @default.
- W2751881420 cites W1985233863 @default.
- W2751881420 cites W1987601236 @default.
- W2751881420 cites W1987878366 @default.
- W2751881420 cites W1991963295 @default.
- W2751881420 cites W1992172691 @default.
- W2751881420 cites W1993387264 @default.
- W2751881420 cites W1994586297 @default.
- W2751881420 cites W1996949194 @default.
- W2751881420 cites W1998939563 @default.
- W2751881420 cites W2000992282 @default.
- W2751881420 cites W2003474213 @default.
- W2751881420 cites W2005475049 @default.
- W2751881420 cites W2005512248 @default.
- W2751881420 cites W2006250811 @default.
- W2751881420 cites W2006434892 @default.
- W2751881420 cites W2008171455 @default.
- W2751881420 cites W2011034592 @default.
- W2751881420 cites W2012707189 @default.
- W2751881420 cites W2012809310 @default.
- W2751881420 cites W2013270956 @default.
- W2751881420 cites W2014427634 @default.
- W2751881420 cites W2015821654 @default.
- W2751881420 cites W2015996393 @default.
- W2751881420 cites W2020439084 @default.
- W2751881420 cites W2021536610 @default.
- W2751881420 cites W2021691065 @default.
- W2751881420 cites W2022687771 @default.
- W2751881420 cites W2023882012 @default.
- W2751881420 cites W2031564220 @default.
- W2751881420 cites W2032903792 @default.
- W2751881420 cites W2034295927 @default.
- W2751881420 cites W2036551119 @default.
- W2751881420 cites W2036916173 @default.
- W2751881420 cites W2039551908 @default.
- W2751881420 cites W2040129605 @default.
- W2751881420 cites W2046822617 @default.
- W2751881420 cites W2052057736 @default.
- W2751881420 cites W2053439872 @default.
- W2751881420 cites W2054092498 @default.
- W2751881420 cites W2056903291 @default.
- W2751881420 cites W2057256078 @default.
- W2751881420 cites W2057848113 @default.
- W2751881420 cites W2058578594 @default.
- W2751881420 cites W2058903721 @default.
- W2751881420 cites W2060394472 @default.
- W2751881420 cites W2062289724 @default.
- W2751881420 cites W2063708209 @default.
- W2751881420 cites W2064674946 @default.
- W2751881420 cites W2064861225 @default.
- W2751881420 cites W2065252231 @default.
- W2751881420 cites W2067796149 @default.
- W2751881420 cites W2069651638 @default.
- W2751881420 cites W2070368404 @default.
- W2751881420 cites W2070695253 @default.
- W2751881420 cites W2071831214 @default.
- W2751881420 cites W2073711993 @default.
- W2751881420 cites W2077241706 @default.
- W2751881420 cites W2079830672 @default.
- W2751881420 cites W2081644109 @default.
- W2751881420 cites W2082511916 @default.
- W2751881420 cites W2087266891 @default.
- W2751881420 cites W2093258954 @default.
- W2751881420 cites W2098799992 @default.
- W2751881420 cites W2101956580 @default.